Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CD Bioparticles
Shirley, New York, United Statescd-bioparticles.com ↗
- Ownership
- Private
- Employees
- ~67
- Development stage
- Commercial
01
Overview
CD Bioparticles does not have its own clinical results or therapeutic pipeline. The company specializes in providing advanced materials—such as nanoparticles, liposomes, polymers—and custom formulation services that support R&D from basic discovery through preclinical studies across academia and industry. Their recent innovations include bio-targeted small molecule-conjugated magnetic nanoparticles aimed at enabling targeted cancer therapy research.
- Therapeutic areas
- Oncology
- Modalities
- NanoparticleLiposome (including PEGylated liposomes)Polymer microsphere and nanoparticleMagnetic particle/bead-based systemsSmall molecule conjugatesHydrogel-based drug delivery therapyProtein/peptide conjugates (via custom services)Exosome-based therapy (offered as isolation kits/tools)
- Industry
- Non-Drug Biotech
02
Partnerships
No major pharmaceutical or biotech partnerships publicly disclosed.
Beyond the preview
Go deeper on CD Bioparticles.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CD Bioparticles.